/PRNewswire/ ViewRay, Inc. (NASDAQ: VRAY) today announced that the company s MRIdian® MRI-Guided Radiation Therapy System will be featured at the 64th.
Program details on keynote addresses, distinguished awards and late-breaking abstracts are being provided by program planners of the American Society for Radiation Oncology (ASTRO) Annual Meeting, set for October 23-26, in San Antonio, TX.